TRACON Pharmaceuticals is a biotechnology business based in the US. TRACON Pharmaceuticals shares (TCON) are listed on the OTCQB and all prices are listed in US Dollars. Its last market close was $0.03 – the same closing value as a week prior. TRACON Pharmaceuticals employs 17 staff and has a trailing 12-month revenue of around $3.2 million.
The Finder Score crunches 147 key metrics we collected directly from 18+ brokers and assessed each provider’s performance based on nine different categories, weighing each metric based on the expertise and insights of Finder’s investment experts. We then scored and ranked each provider to determine the best brokerage accounts.
We update our best picks as products change, disappear or emerge in the market. We also regularly review and revise our selections to ensure our best provider lists reflect the most competitive available.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $0.03 |
|---|---|
| 52-week range | $0.02 - $2.06 |
| 50-day moving average | $0.03 |
| 200-day moving average | $0.06 |
| Wall St. target price | $6.00 |
| PE ratio | 0.0054 |
| Dividend yield | N/A |
| Earnings per share (TTM) | $5.93 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $0.0322 from 2025-05-09
| 1 week (2025-05-02) | 0.0322 |
|---|---|
| 1 month (2025-04-11) | 0.0322 |
| 3 months (2025-02-12) | 0.0322 |
| 6 months (2024-11-12) | -44.29% |
| 1 year (2024-05-10) | -98.33% |
|---|---|
| 2 years (2023-05-11) | -99.76% |
| 3 years (2022-05-11) | 35.6 |
| 5 years (2020-05-11) | 40 |
Valuing TRACON Pharmaceuticals stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of TRACON Pharmaceuticals's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
TRACON Pharmaceuticals's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 0x. In other words, TRACON Pharmaceuticals shares trade at around 0x recent earnings.
| Revenue TTM | $3.2 million |
|---|---|
| Gross profit TTM | $-8,906,000 |
| Return on assets TTM | -59.37% |
| Return on equity TTM | -1277.01% |
| Profit margin | 162.34% |
| Book value | $-0.91 |
| Market Capitalization | $109,725 |
TTM: trailing 12 months
We're not expecting TRACON Pharmaceuticals to pay a dividend over the next 12 months.
TRACON Pharmaceuticals's shares were split on a 1:20 basis on 9 April 2024 . So if you had owned 20 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your TRACON Pharmaceuticals shares – just the quantity. However, indirectly, the new 1900% higher share price could have impacted the market appetite for TRACON Pharmaceuticals shares which in turn could have impacted TRACON Pharmaceuticals's share price.
Over the last 12 months, TRACON Pharmaceuticals's shares have ranged in value from as little as $0.021 up to $2.06. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (OTCQB average) beta is 1, while TRACON Pharmaceuticals's is 1.422. This would suggest that TRACON Pharmaceuticals's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
TRACON Pharmaceuticals, Inc. , a biopharmaceutical company, focuses on the development and commercialization of novel targeted therapeutics for cancer in the United States. Its clinical stage products include envafolimab (KN035), a PD-L1 single-domain antibody for the treatment of refractory soft tissue sarcoma; and YH001, an investigational humanized cytotoxic T-lymphocyte-associated protein 4 IgG1 monoclonal antibody that is in Phase I clinical trial for the treatment of various cancer indications. The company's clinical stage products also include TRC102, a small molecule that is in Phase II clinical trial for the treatment of mesothelioma, and in Phase I clinical trial to treat solid tumors, lung cancer, and glioblastoma; and TJ004309, a CD73 antibody that is in Phase I clinical development for the treatment of solid tumors. In addition, it is developing bispecific antibodies, which are in preclinical stage. It has collaboration and license agreements with 3D Medicines Co. , Ltd.
We dug through 60 years of Berkshire Hathaway annual shareholder letters to bring you 9 lessons from Warren Buffett: “The Oracle of Omaha.”
Our picks of the best brokerage accounts for index funds for beginners, teens, proprietary funds and more.
Cash sweep accounts let you earn interest on your uninvested cash. Learn how they work and how to choose the best one here.
eToro is a robust trading platform with an easy-to-use interface and no commissions on stocks and ETFs.
Check out our picks of the best trading apps for beginners, options traders, hands-off investors and more.
Thinking of switching from Moomoo? Here are 5 apps like Moomoo that offer valuable benefits
We’ve rounded up stats on some of the most popular graphene stocks, along with information on how they compare and how to invest.
See our picks of the best brokerage accounts, including Fidelity, SoFi, Charles Schwab, Public, Robinhood and E*TRADE .
Webull is a broker with zero-commission trading and a suite of tools to help you invest.
Here’s what you need to know about how to buy and sell stocks online in this easy to follow, step-by-step guide.